Pharma IQ Members

Shipper saves $0.5 million by escaping the sting of product rejection

PLUSS
Posted: 09/01/2017

Temperature excursions in the healthcare industry have recently resulted in losses of around $35 billion - Half of this figure is due to product spoilage.

The high cost of spoiled pharmaceutical products is one of the driving motives for using Phase Change Materials (PCMs) in supply chains. 

Vishnu Sasidharan – VP New Product Initiatives, of Pluss examines the key decision making metrics for PCMs, the benefits of using these materials in stubborn emerging markets and provides insight into one case study where a firm saw significant savings from switching to PCMs. 

Benefits of reading this eBookChallenges Addressed
  • Gain an insight on the value proposition of implementing PCMs and the differentiation over conventional solution.
  • Download a brief on critical parameters to consider while evaluating PCMs and technical capabilities of the manufacturer
  • Regulatory compliances against use of hazardous coolants and materials for passive cooling.
  • Ensuring precision in temperature control for temperature sensitive, high value pharmaceutical drugs and products.
  • Standardization and fool-proofing the process of packaging with use of PCMs by reduction of number of steps and components involved in pharmaceutical packaging.
To continue viewing this content please fill out the form below and become an Cold Chain IQ member.
Or if you're already a Cold Chain IQ member, sign in below to download.
Subscribe

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

PLUSS
Posted: 09/01/2017